Science

Dec 24, 2024, 00:24

Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer

Ryan Nipp, Oncologist at University of Oklahoma, shared a recent article by Anne Gulbech Ording on X:

“Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer in Routine Clinical Practice: A Nationwide Cohort Study.”

Title: Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer in Routine Clinical Practice: A Nationwide Cohort Study

Authors: Anne Gulbech Ording, Flemming Skjøth, Laurids Østergaard Poulsen, Weronika Maria Szejniuk, Erik Jakobsen, Thomas Decker Christensen, Simon Noble and Thure Filskov Overvad

Lung Cancer

Ryan Nipp, M.D., MPH, gastrointestinal oncologist and cancer outcomes researcher at OU Health Stephenson Cancer Center. His research platform consists of studies interfacing between palliative care, geriatric oncology and health services research. He completed an internal medicine residency at Duke University and oncology fellowship at Dana-Farber/Harvard Cancer Center.

More posts featuring Ryan Nipp.

Anne Gulbech Ording anticancer therapy cancer Flemming Skjøth Laurids Østergaard Poulsen Lung cancer OncoDaily Oncology Ryan Nipp therapy Thure Filskov Overvad toxicity University of Oklahoma Weronika Maria Szejniuk

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers